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Matrix stiffness is an important microenvironmental cue that regulates cell growth, motility, and differentia-
tion. In a recent Cell report, Weaver and colleagues implicate lysyl-oxidase-mediated collagen crosslinking
as a contributor to tumor matrix stiffening, which leads to enhanced integrin signaling and invasive behavior
in tumors.Cells in most tissues interact with an
elastic microenvironment that provides
not only chemical signals but also inputs
of a physical nature. The mechanical
properties of a cell’s microenvironment
can play a significant role in governing
cellular behaviors. For example, matrix
stiffness can direct differentiation of
mesenchymal stem cells into distinct line-
ages, consistent with differences in tissue
compliance (Engler et al., 2006). Matrix
stiffness has also been implicated in
tumorigenesis; both tumor cells and adja-
cent stroma display increased stiffness
compared to normal tissues (Paszek
et al., 2005). Tumor-associated stroma is
composed of several cell types including
adipocytes, fibroblasts, and immune cells,
as well as a variety of extracellular matrix
(ECM) proteins, such as collagen and
fibronectin. What causes the increase in
tumor stromal stiffness and how stromal
stiffness contributes to tumor progression
have become central questions in exam-
ining tumorigenesis from the mechan-
ical-chemical perspective. The recent
report by Weaver and colleagues (Leven-
tal et al., 2009) provides some answers to
these questions.
Elevated deposition of fibrillar collagen,
the most abundant ECM protein in the
stroma, has been particularly associated
with an altered stroma during breast
tumorigenesis, correlating with increased
mammographic density and greater
breast cancer risk (Provenzano et al.,
2006). It was discovered that increased
collagen gel density or concentration
increases matrix stiffness and disrupts
mammary morphogenesis in 3D culture
systems (Paszek et al., 2005; Provenzano
et al., 2009). Furthermore, reduction of
collagen degradation in an engineeredmouse model increased stromal collagen
density in mammary tissues and the inci-
dence of mammary tumors (Provenzano
et al., 2008). Evidence therefore pointed
to collagen as a significant contributor to
the changes in cellular mechanical micro-
environment that accompanies tumor
progression.
As the links between stromal collagen
density, matrix stiffness, and tumor pro-
gression solidify, the underlying molecular
mechanisms are slowly unraveling. The
report by Weaver and colleagues contrib-
utes further insights by establishing
a correlation between collagen crosslink-
ing and matrix stiffness in vivo and by
implicating the ECM-crosslinking enzyme
lysyl oxidase (LOX) as a culprit driving
stiffness-associated tumor progression
(Levental et al., 2009). By conditioning
mammary fat pads with fibroblasts
expressing constitutively active LOX, the
authors artificially increased collagen
crosslinking in mouse mammary stroma
and found that not only were the tissues
stiffened, but the conditioned glands also
promoted growth and invasion of normally
noninvasive mammary epithelial cells
(Figure 1). Conversely, inhibition of LOX
wasfound to reducebreast tumorprogres-
sion in a mouse model. Importantly, it was
demonstrated that LOX-mediated tumor
progression is probably due to extracel-
lular LOX modifications of the tumor
microenvironment rather than intracellular
LOX signaling in the tumor cells.
The implication that LOX alters the
tumor microenvironment and promotes
tumor progression follows previous
evidence linking LOX in tumorigenesis.
LOX protein expression is elevated in
many types of tumors, is associated with
poor prognosis, and is shown to beCancer Cell 16,involved in recruiting inflammatory stro-
mal cells that contribute to tumor progres-
sion (Erler et al., 2009). These findings
together support the potential therapeutic
value in targeting LOX for cancer treat-
ment. Questions still remain, however,
regarding the origin and regulation of
LOX expression and secretion, as well
as its mechanism of action during
tumorigenesis. Weaver and colleagues
described elevated LOX in mouse mam-
mary tumor stroma and used LOX-
expressing fibroblasts to promote tumor
progression, yet LOX was reported to be
secreted by tumor cells themselves in
response to hypoxia (Erler et al., 2009).
Aside from collagen, LOX can also cross-
link the ECM protein elastin and has
been found to interact with fibronectin,
another stromal ECM component that
can modulate matrix stiffness (Payne
et al., 2007). Intriguingly, LOX may also
play intracellular roles in tumorigenesis
and may in fact play a dichotomous role
as a tumor suppressor (Payne et al.,
2007); its action in crosslinking the ECM
may oppose the role of matrix metallopro-
teases (MMPs), which promote tumor
progression via matrix degradation. LOX
is likely to collaborate with MMPs to
generate a dynamic microenvironment
that mechanically and chemically influ-
ences tumorigenesis.
Matrix remodeling represents only one
of a complex set of processes that govern
tumor development. Another critical
insight revealed by the study of Weaver
and colleagues is that increased matrix
stiffness alone cannot promote tumor
invasion. Acini cultured in collagen-I-con-
taining basement membrane gels stiffened
by ribose-induced collagen crosslinking
displayed disrupted morphology but noDecember 8, 2009 ª2009 Elsevier Inc. 455
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Figure 1. Increased Collagen Crosslinking Increases Matrix Stiffness and Promotes Tumor
Invasion In Vivo and In Vitro
Weaver and colleagues found that preconditioning of the mammary fat pad with LOX-expressing fibro-
blasts increases matrix stiffness and enhances the growth and invasion of Ha-Ras premalignant mammary
organoids. Similarly, crosslinking of collagen gels with ribose results in invasive structures in 3D mammary
epithelial cell (MEC) cultures induced to express the activated oncogene ErbB2. Studies in this and
previous reports demonstrate that collagen crosslinking-mediated matrix stiffening increases integrin
clustering, which leads to phosphorylation of focal adhesion kinase (pFAK) and Crk-associated substrate
(pCas), as well as activation of the AKT, ERK, and Rho pathways. Not shown are other cell types and ECM
proteins present in the mammary tissue, which may also play important roles in tumorigenesis but are not
discussed in Levental et al. (2009).invasive structures develop unless the
oncogene ErbB2 was activated (Figure 1).
By using a mutant variant of b1-integrin
that clusters constitutively to mimic the
effects of stiff matrix, the authors similarly
observed that invasion occurred only with
Ha-Ras-transformed mammary epithelial
cells and not with normal cells. Tumor
progression and malignancy therefore
require cooperation between the mechan-
ical microenvironment and the intrinsic
cell states.
How such cooperation is orchestrated
is not well understood. Mechanical prop-
erties of the microenvironment are sensed
by integrin family receptors that connect
ECM proteins outside the cell to the actin
cytoskeleton inside the cell (Chen, 2008).
Increased tension from stiffer matrix
induces integrin clustering, the develop-
ment of focal adhesions, and the activa-
tion of multiple downstream signaling
pathways. Consistent with this, Weaver
and colleagues showed that tumors
developing in stroma that contains LOX-456 Cancer Cell 16, December 8, 2009 ª200crosslinked collagen display elevated
integrin signaling, including phosphoryla-
tion of focal adhesion kinase (FAK) and
Cas (Levental et al., 2009). They also
found that the PI3-kinase substrate AKT
is hyperactivated in stiffer tumors.
FAK phosphorylation is known to signal
the Rho pathway, which influences cell
contractility by mediating cytoskeletal
processes such as focal adhesion and
actin stress fiber formations (Chen,
2008). The Weaver laboratory had previ-
ously found that Rho activity is increased
in cells on stiffer 2D substrates (Paszek
et al., 2005), a result corroborated
recently by the Keely laboratory with
evidence from 3D mammary epithelial
cell cultures (Provenzano et al., 2009). In
parallel, enhanced FAK activation on
stiffer matrix can also increase the phos-
phorylation of extracellular signal-regu-
lated kinase (ERK) via Ras activation
(Paszek et al., 2005; Provenzano et al.,
2009). ERK can control cell migration,
invasion, proliferation, and differentiation9 Elsevier Inc.through modulation of acto-myosin con-
traction as well as induction of transcrip-
tional programs, some of which have
recently been found to respond differen-
tially to stiff and soft microenvironments
(Provenzano et al., 2009). Similarly, AKT
can also modulate multiple cellular
programs that regulate motility, growth,
proliferation, and metabolism (Manning
and Cantley, 2007). Importantly, the Rho,
ERK, and AKT pathways are all strongly
implicated in cancer. The intersection
between mechanotransduction pathways
with oncogenic signaling pathways is
probably not coincidental; in fact, they
may be synergistic in promoting tumor
malignancy. For example, stiffness-
dependent ERK activation may augment
chronic activation of the ERK pathway
in tumor cells that overexpress ErbB2 or
Ras, leading to the invasive behavior
seen by Weaver and colleagues. Eluci-
dating the crosstalk between mechano-
transduction and oncogenic signaling
will be an important next step toward
understanding the complex reciprocal
interactions between tumors and their
microenvironment.
Thus, while Weaver and colleagues
pinpoint one microenvironmental factor—
LOX-mediated collagen crosslinking—
as a contributor to stromal stiffening
that leads to breast tumor progression,
their work also promotes an under-
standing of cancer not only as dysregu-
lated cellular signaling and behaviors,
but also as a context-dependent patho-
logy where tumor cells interact with
and respond to their physical microenvi-
ronment. Understanding tumor-stroma
interactions, especially how extracellular
mechanical and chemical signals inte-
grate with intrinsic genetic and epigenetic
alterations in tumor cells to regulate tumor
progression, will be crucial in combating
cancer.
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